0001209191-13-053774.txt : 20131122 0001209191-13-053774.hdr.sgml : 20131122 20131122161943 ACCESSION NUMBER: 0001209191-13-053774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131120 FILED AS OF DATE: 20131122 DATE AS OF CHANGE: 20131122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDASSETS INC CENTRAL INDEX KEY: 0001254419 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 510391128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 BUSINESS PHONE: 6783232500 MAIL ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rutherford John C CENTRAL INDEX KEY: 0001311158 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33881 FILM NUMBER: 131238452 MAIL ADDRESS: STREET 1: C/O INTERLINE BRANDS, INC. STREET 2: 801 W. BAY STREET CITY: JACKSONVILLE STATE: FL ZIP: 32004-1605 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-11-20 0 0001254419 MEDASSETS INC MDAS 0001311158 Rutherford John C 100 NORTH POINT CENTER EAST SUITE 200 ALPHARETTA GA 30022 1 0 0 0 Common Stock 2013-11-20 4 S 0 2540 20.60 D 40292 D Common Stock 2013-11-21 4 S 0 9460 20.70 D 30832 D Restricted Stock 5944 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $20.62, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $20.78, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted. /s/ Christopher K. Logsdon, Attorney-In-Fact 2013-11-22